DE69614096T2 - Verfahren zur herstellung einer festen arzneimitteldosierungsform - Google Patents

Verfahren zur herstellung einer festen arzneimitteldosierungsform

Info

Publication number
DE69614096T2
DE69614096T2 DE69614096T DE69614096T DE69614096T2 DE 69614096 T2 DE69614096 T2 DE 69614096T2 DE 69614096 T DE69614096 T DE 69614096T DE 69614096 T DE69614096 T DE 69614096T DE 69614096 T2 DE69614096 T2 DE 69614096T2
Authority
DE
Germany
Prior art keywords
dosage form
producing
mixture
drug dosage
solid drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69614096T
Other languages
English (en)
Other versions
DE69614096D1 (de
Inventor
William Jordan
Elaine Saunders
Patrick Kearney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of DE69614096D1 publication Critical patent/DE69614096D1/de
Application granted granted Critical
Publication of DE69614096T2 publication Critical patent/DE69614096T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
DE69614096T 1995-03-02 1996-03-01 Verfahren zur herstellung einer festen arzneimitteldosierungsform Expired - Lifetime DE69614096T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504201.6A GB9504201D0 (en) 1995-03-02 1995-03-02 Process for the preparation of a solid pharmaceutical dosage form
PCT/GB1996/000483 WO1996026714A1 (en) 1995-03-02 1996-03-01 Process for the preparation of a solid pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
DE69614096D1 DE69614096D1 (de) 2001-08-30
DE69614096T2 true DE69614096T2 (de) 2002-03-21

Family

ID=10770527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614096T Expired - Lifetime DE69614096T2 (de) 1995-03-02 1996-03-01 Verfahren zur herstellung einer festen arzneimitteldosierungsform

Country Status (13)

Country Link
US (1) US6423342B1 (de)
EP (1) EP0814770B1 (de)
JP (1) JP2969002B2 (de)
AT (1) ATE203397T1 (de)
AU (1) AU4884596A (de)
DE (1) DE69614096T2 (de)
DK (1) DK0814770T3 (de)
ES (1) ES2160232T3 (de)
GB (1) GB9504201D0 (de)
GR (1) GR3036516T3 (de)
PT (1) PT814770E (de)
WO (1) WO1996026714A1 (de)
ZA (1) ZA961734B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106241A1 (en) * 1995-02-03 2005-05-19 Brewer Francesca M. Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors
GB9715082D0 (en) * 1997-07-17 1997-09-24 Scherer Ltd R P Treatment of attention deficit hyperactivity disorder and narcolepsy
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
CA2588293C (en) * 2004-11-24 2013-07-02 Teva Pharmaceutical Industries Ltd. Rasagiline orally disintegrating compositions
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
WO2011026080A1 (en) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
JP7219712B2 (ja) 2016-10-13 2023-02-08 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 膣送達のための凍結乾燥医薬組成物
WO2021222739A1 (en) 2020-04-30 2021-11-04 Nanocopoeia, Llc Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB2111423B (en) * 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
AUPR666101A0 (en) 2001-07-27 2001-08-16 Inflatable Image Technologies Pty. Limited Inflatable images
DE10144308A1 (de) 2001-09-10 2003-03-27 Haarmann & Reimer Gmbh Verfahren zur Transformation von Amycolatopsis sp. DSM 9991 und DSM 9992

Also Published As

Publication number Publication date
EP0814770A1 (de) 1998-01-07
US6423342B1 (en) 2002-07-23
DE69614096D1 (de) 2001-08-30
JPH10506408A (ja) 1998-06-23
GB9504201D0 (en) 1995-04-19
ZA961734B (en) 1996-11-01
EP0814770B1 (de) 2001-07-25
PT814770E (pt) 2001-11-30
ATE203397T1 (de) 2001-08-15
AU4884596A (en) 1996-09-18
WO1996026714A1 (en) 1996-09-06
GR3036516T3 (en) 2001-12-31
JP2969002B2 (ja) 1999-11-02
DK0814770T3 (da) 2001-11-05
ES2160232T3 (es) 2001-11-01

Similar Documents

Publication Publication Date Title
DE69609958T2 (de) Verfahren zur herstellung von produkten, die bisalze der ameisensäure enthalten
ATE130604T1 (de) Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE184480T1 (de) Verfahren zur herstellung von arzneizubereitungen mit verzögerter wirkstoffabgabe
DE69207799D1 (de) Pharmazeutische Zubereitung mit verzögerter Wirkstoffreigabe und Verfahren zur Herstellung derselben
ATE314075T1 (de) Verfahren zur herstellung diphosphonsäure enthaltende feste pharmazeutische darreichungsformen
ATE87469T1 (de) Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
DE19681560T1 (de) Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
ES2076412T3 (es) Proceso para la fabricacion de microesferas.
DE69614096T2 (de) Verfahren zur herstellung einer festen arzneimitteldosierungsform
ATE122559T1 (de) Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung.
ATE137753T1 (de) Codeinsalz einer substituierten carbonsäure, verfahren zu seiner herstellung, seine verwendung und pharmazeutische präparate
ATA863176A (de) Verfahren zur herstellung von neuen ver- bindungen aus einem copolymeren des vinylengly- clos und einer daran chemisch gebundenen biologisch aktiven substanz
DE69114721D1 (de) Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.
KR890006644A (ko) 결정성 β-락탐 수화물
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE69103922T2 (de) Verfahren zur Herstellung arzneistoffhaltiger Tabletten mit verzögerter Freigabe.
DE69513827D1 (de) Verfahren zur herstellung von optisch aktiven alpha-substituierten carbonsäurederivaten
DE69113840T2 (de) Verfahren zur Herstellung von 2-Halogeno-3-Hydroxy-3-Phenyl-Propionsäureesterverbindungen.
DE69304634T2 (de) Verfahren zur Herstellung von N,O-Dialkylhydroxycarbaminsäureestern
DE59008858D1 (de) Verfahren zur Synthese von Methyl-(2-carboalkoxy-ethyl)-phosphinsäurealkylestern.
DE50104847D1 (de) Verfahren zur herstellung chiraler verbindungen
DE59001152D1 (de) Verfahren zur herstellung von nitro-benzoesaeure-alkylestern.
ATA902489A (de) Verfahren zur herstellung von chinolincarbonsäurederivaten
AT385990B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven eburnan-oxim-derivaten sowie von saeureadditions-salzen derselben

Legal Events

Date Code Title Description
8364 No opposition during term of opposition